Generex Biotechnology Corp (GNBT) financial statements (2022 and earlier)

Company profile

Business Address 10102 USA TODAY WAY
MIRAMAR, FL 33025
State of Incorp. DE
Fiscal Year End July 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

7/31/2020
7/31/2019
7/31/2018
7/31/2017
7/31/2016
7/31/2015
7/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments152981,0462,879177503,269
Cash and cash equivalents152981,0462,879177503,269
Inventory, net of allowances, customer advances and progress billings7423631210   
Inventory7423631210   
Intangible current assets     108291
Other current assets3322769622851201
Other undisclosed current assets1653634  (108)(291)
Total current assets:1,2559741,1882,911258013,471
Noncurrent Assets
Operating lease, right-of-use asset38 
Property, plant and equipment214500321135
Intangible assets, net (including goodwill)37,55239,3813,1882,911 1,4302,046
Goodwill34,48938,298     
Intangible assets, net (excluding goodwill)3,0631,0833,1882,911 1,4302,046
Other undisclosed noncurrent assets6,3248,7822,1994,272   
Total noncurrent assets:44,12848,6625,4197,18311,4332,052
TOTAL ASSETS:45,38349,6366,60710,095262,2345,522
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:23,90819,05611,04510,1738,9518,0198,034
Accounts payable1,316   3,7513,1573,208
Accrued liabilities    326326327
Employee-related liabilities    312357206
Interest and dividends payable3,911      
Other undisclosed accounts payable and accrued liabilities18,68119,05611,04510,1734,5624,1784,293
Debt11,166      
Derivative instruments and hedges, liabilities1,317     2,636
Deferred revenue and credits   224
Other undisclosed current liabilities4,9819,89014,18413,73850 (2,636)
Total current liabilities:41,37128,94625,22923,9119,0018,0198,258
Noncurrent Liabilities
Long-term debt and lease obligation500      
Long-term debt, excluding current maturities500      
Liabilities, other than long-term debt1,3177,820  2,0492,3632,636
Derivative instruments and hedges, liabilities1,3177,820  2,0492,3632,636
Other undisclosed noncurrent liabilities10,079(7,035)24,96366,060193142719
Total noncurrent liabilities:11,89678524,96366,0602,2422,5063,355
Other undisclosed liabilities 8,158     
Total liabilities:53,26737,88950,19289,97111,24310,52411,613
Temporary equity, carrying amount4,0744,074     
Stockholders' equity
Stockholders' equity attributable to parent, including:(11,958)7,673(43,585)(79,876)(11,217)(8,290)(6,090)
Common stock826211909825779
Additional paid in capital429,744408,567368,410368,410362,780362,557362,308
Accumulated other comprehensive income780797798783799809772
Accumulated deficit(452,063)(418,728)  (375,704)(372,481) 
Warrants and rights outstanding     2,363 
Other undisclosed stockholders' equity attributable to parent9,49816,974(412,794)(449,070) (2,363)(369,948)
Total stockholders' equity:(11,958)7,673(43,585)(79,876)(11,217)(8,290)(6,090)
TOTAL LIABILITIES AND EQUITY:45,38349,6366,60710,095262,2345,522

Income statement (P&L) ($ in thousands)

7/31/2020
7/31/2019
7/31/2018
7/31/2017
7/31/2016
7/31/2015
7/31/2014
Revenues 6,204703    
Cost of revenue(580)(4,138)    (600)
Cost of goods and services sold (645)    (600)
Other undisclosed gross profit2,661      
Gross profit:2,0822,065703   (600)
Operating expenses(20,019)(26,411)(3,199)(1,597)(1,903)(3,883)(4,400)
Other undisclosed operating income      600
Operating loss:(17,937)(24,345)(2,496)(1,597)(1,903)(3,883)(4,400)
Nonoperating income
(Investment Income, Nonoperating)
  700  0194
Interest and debt expense(7,104)(7,104)(584)(743)(419)(22)(322)
Loss before gain (loss) on sale of properties:(25,041)(31,449)(2,379)(2,340)(2,321)(3,905)(4,527)
Other undisclosed net income     1,7124,526
Net loss:(25,041)(31,449)(2,379)(2,340)(2,321)(2,193)(1)
Net income attributable to noncontrolling interest8971,6653856,816   
Other undisclosed net income (loss) attributable to parent(10,088)18,77737,943(81,309)(902)  
Net income (loss) attributable to parent:(34,232)(11,007)35,949(76,833)(3,223)(2,193)(1)
Preferred stock dividends and other adjustments     (340)(2,058)
Other undisclosed net income available to common stockholders, basic8971,6653856,816   
Net income (loss) available to common stockholders, diluted:(33,335)(9,341)36,334(70,016)(3,223)(2,533)(2,060)

Comprehensive Income ($ in thousands)

7/31/2020
7/31/2019
7/31/2018
7/31/2017
7/31/2016
7/31/2015
7/31/2014
Net loss:(25,041)(31,449)(2,379)(2,340)(2,321)(2,193)(1)
Comprehensive loss:(25,041)(31,449)(2,379)(2,340)(2,321)(2,193)(1)
Comprehensive income, net of tax, attributable to noncontrolling interest8971,6653856,816   
Other undisclosed comprehensive income, net of tax, attributable to parent     37 
Comprehensive income (loss), net of tax, attributable to parent:(24,144)(29,784)(1,994)4,476(2,321)(2,157)(1)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: